UK markets closed

Basilea Pharmaceutica AG (BPMUF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
44.450.00 (0.00%)
At close: 01:56PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 528.25M
Enterprise value 603.38M
Trailing P/E 47.13
Forward P/E 19.76
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.12
Price/book (mrq)N/A
Enterprise value/revenue 3.83
Enterprise value/EBITDA 25.96

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-14.52%
S&P500 52-week change 321.08%
52-week high 352.00
52-week low 338.60
50-day moving average 341.64
200-day moving average 344.08

Share statistics

Avg vol (3-month) 38
Avg vol (10-day) 3N/A
Shares outstanding 512M
Implied shares outstanding 612.01M
Float 811.63M
% held by insiders 10.06%
% held by institutions 137.04%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 6.63%
Operating margin (ttm)-22.51%

Management effectiveness

Return on assets (ttm)6.95%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)157.63M
Revenue per share (ttm)13.15
Quarterly revenue growth (yoy)-19.30%
Gross profit (ttm)N/A
EBITDA 23.18M
Net income avi to common (ttm)10.45M
Diluted EPS (ttm)0.94
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)59.93M
Total cash per share (mrq)4.99
Total debt (mrq)128.61M
Total debt/equity (mrq)N/A
Current ratio (mrq)3.20
Book value per share (mrq)-0.83

Cash flow statement

Operating cash flow (ttm)14.24M
Levered free cash flow (ttm)8.51M